Correction: Targeting the HIF-1α-IGFBP2 axis therapeutically reduces IGF1-AKT signaling and blocks the growth and metastasis of relapsed anaplastic Wilms tumor
1 Division of Cancer and Immunology Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA. yanliu@ihv.umaryland.edu.
2 Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC, USA.
3 Division of Cancer and Immunology Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA.
4 OncoC4, Inc, Rockville, MD, USA.
5 Division of Cancer and Immunology Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA. yangl@oncoc4.com.
6 OncoC4, Inc, Rockville, MD, USA. yangl@oncoc4.com.
7 Division of Cancer and Immunology Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD, USA. ywang@ihv.umaryland.edu.